🔎 Trials Near Me

Home › Leukemia › Connecticut › New Haven

Pag-aaral pangklinika para sa Leukemia sa New Haven, CT

Isang pag-aaral para sa Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New Haven. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)

Nagre-recruitPhase 3
  • Research Site, New Haven
Edad 18 hanggang 18 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07509151

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1
  • Smilow Cancer Hospital at Yale New Haven, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT06001788

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Nagre-recruitPhase 3
  • Yale University School of Medicine, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07007312

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Nagre-recruitPhase 1/2
  • Dren Investigational Site, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral
  • Yale University, New Haven
Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Nagre-recruitPhase 2/3
  • Yale University, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT04256317

Revumenib in Combination With 7+3 + Midostaurin in AML

Nagre-recruitPhase 1
  • Yale Cancer Center, New Haven
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 25, 2026 · NCT06313437

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Nagre-recruitPhase 1
  • Yale Cancer Center and Smilow Cancer Hospital, New Haven
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT05735184

Pag-aaral para sa Leukemia sa ibang lungsod

Iba pang pag-aaral sa New Haven

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.